Invention Publication
- Patent Title: SOLID STATE FORMS OF (S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)AMINO)-N-(1-(2-METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE AND USES THEREOF
-
Application No.: US18160442Application Date: 2023-01-27
-
Publication No.: US20230167069A1Publication Date: 2023-06-01
- Inventor: Elaine GREER , Stephen ANDERSON , Mark MALONEY , Shu YU , Ekaterina ALBERT , Emily RIGSBEE
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- The original application number of the division: US17180296 2021.02.19
- Main IPC: C07D233/88
- IPC: C07D233/88
Abstract:
The present disclosure relates to: a) solid state forms of hydrobromide salts of Compound 1; b) pharmaceutical compositions comprising one or more solid state forms of hydrobromide salts of Compound 1, and, optionally, a pharmaceutically acceptable carrier; c) methods of treating tumors or cancers by administering one or more solid state forms of hydrobromide salts of Compound 1 to a subject in need thereof; and d) methods for the preparation of solid state forms of Compound 1.
Public/Granted literature
Information query
